129 related articles for article (PubMed ID: 32394866)
1. [Focus on the Myocardial Hypertrophy from the Perspective of Transcriptomics and Metabolomics].
Shakaryants GA; Kozhevnikova MV; Kaplunova VY; Privalova EV; Lishuta AS; Korobkova EO; Belenkov YN
Kardiologiia; 2020 Mar; 60(4):120-129. PubMed ID: 32394866
[TBL] [Abstract][Full Text] [Related]
2. [Metabolomic Profiling of Patients With Cardiovascular Diseases].
Belenkov YN; Privalova EV; Kozhevnikova MV; Korobkova EO; Ilgisonis IS; Kaplunova VY; SHakaryants GA; Appolonova SA; Kuharenko AV; Larcova EV; Mesonzhik NV
Kardiologiia; 2018 Sep; 58(9):59-62. PubMed ID: 30295200
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics and Heart Diseases: From Basic to Clinical Approach.
Barba I; Andrés M; Garcia-Dorado D
Curr Med Chem; 2019; 26(1):46-59. PubMed ID: 28990507
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics in cardiovascular diseases.
Kordalewska M; Markuszewski MJ
J Pharm Biomed Anal; 2015 Sep; 113():121-36. PubMed ID: 25958299
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics: a new era in cardiology?
Mercuro G; Bassareo PP; Deidda M; Cadeddu C; Barberini L; Atzori L
J Cardiovasc Med (Hagerstown); 2011 Nov; 12(11):800-5. PubMed ID: 21934525
[TBL] [Abstract][Full Text] [Related]
6. Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association.
Cheng S; Shah SH; Corwin EJ; Fiehn O; Fitzgerald RL; Gerszten RE; Illig T; Rhee EP; Srinivas PR; Wang TJ; Jain M;
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28360086
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic strategies to study lipotoxicity in cardiovascular disease.
Waterman CL; Kian-Kai C; Griffin JL
Biochim Biophys Acta; 2010 Mar; 1801(3):230-4. PubMed ID: 19944186
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomics and metabolomics reveal the cardioprotective effect of Compound Danshen tablet on isoproterenol-induced myocardial injury in high-fat-diet fed mice.
Wu P; Zhang Z; Ma G; Li J; Zhou W
J Ethnopharmacol; 2020 Jan; 246():112210. PubMed ID: 31479707
[TBL] [Abstract][Full Text] [Related]
9. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
Ussher JR; Elmariah S; Gerszten RE; Dyck JR
J Am Coll Cardiol; 2016 Dec; 68(25):2850-2870. PubMed ID: 28007146
[TBL] [Abstract][Full Text] [Related]
10. Maternal obesity induces cardiac hypertrophy and sex-specific myocardial transcriptomic and metabolomic alterations.
Robinson GI; Gerasymchuk M; Dubiel J; Miller JGP; Groves A; Haselhorst L
J Physiol; 2022 Jul; 600(14):3221-3223. PubMed ID: 35695061
[No Abstract] [Full Text] [Related]
11. Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.
Shah SH; Newgard CB
Circ Cardiovasc Genet; 2015 Apr; 8(2):410-9. PubMed ID: 25901039
[TBL] [Abstract][Full Text] [Related]
12. Stress response and tolerance mechanisms of ammonia exposure based on transcriptomics and metabolomics in Litopenaeus vannamei.
Xiao J; Li QY; Tu JP; Chen XL; Chen XH; Liu QY; Liu H; Zhou XY; Zhao YZ; Wang HL
Ecotoxicol Environ Saf; 2019 Sep; 180():491-500. PubMed ID: 31121556
[TBL] [Abstract][Full Text] [Related]
13. Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases.
Dang VT; Huang A; Werstuck GH
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):166-175. PubMed ID: 29683098
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects.
Rizza S; Copetti M; Rossi C; Cianfarani MA; Zucchelli M; Luzi A; Pecchioli C; Porzio O; Di Cola G; Urbani A; Pellegrini F; Federici M
Atherosclerosis; 2014 Feb; 232(2):260-4. PubMed ID: 24468136
[TBL] [Abstract][Full Text] [Related]
15. Integrated application of transcriptomics and metabolomics provides insights into unsynchronized growth in pearl oyster Pinctada fucata martensii.
Hao R; Du X; Yang C; Deng Y; Zheng Z; Wang Q
Sci Total Environ; 2019 May; 666():46-56. PubMed ID: 30784822
[TBL] [Abstract][Full Text] [Related]
16. Omics studies for comprehensive understanding of immunoglobulin A nephropathy: state-of-the-art and future directions.
Schena FP; Serino G; Sallustio F; Falchi M; Cox SN
Nephrol Dial Transplant; 2018 Dec; 33(12):2101-2112. PubMed ID: 29905852
[TBL] [Abstract][Full Text] [Related]
17. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment.
Dona AC; Coffey S; Figtree G
Eur J Prev Cardiol; 2016 Oct; 23(15):1578-89. PubMed ID: 27103630
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics and ischaemic heart disease.
Rasmiena AA; Ng TW; Meikle PJ
Clin Sci (Lond); 2013 Mar; 124(5):289-306. PubMed ID: 23157406
[TBL] [Abstract][Full Text] [Related]
19. New insights into cardiovascular and lipid metabolomics.
Giovane A; Balestrieri A; Napoli C
J Cell Biochem; 2008 Oct; 105(3):648-54. PubMed ID: 18729082
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
